Dr. Martens plc (LON:DOCS - Get Free Report) insider Giles Wilson acquired 189 shares of Dr. Martens stock in a transaction dated Wednesday, June 11th. The shares were acquired at an average price of GBX 79 ($1.07) per share, with a total value of £149.31 ($202.29).
Giles Wilson also recently made the following trade(s):
- On Friday, April 11th, Giles Wilson acquired 297 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 51 ($0.69) per share, with a total value of £151.47 ($205.22).
- On Tuesday, March 25th, Giles Wilson acquired 32,640 shares of Dr. Martens stock. The shares were acquired at an average price of GBX 54 ($0.73) per share, with a total value of £17,625.60 ($23,879.69).
Dr. Martens Stock Down 3.0%
Dr. Martens stock traded down GBX 2.30 ($0.03) during midday trading on Friday, hitting GBX 74.20 ($1.01). 2,407,124 shares of the stock were exchanged, compared to its average volume of 2,279,323. Dr. Martens plc has a 52-week low of GBX 43.02 ($0.58) and a 52-week high of GBX 85.10 ($1.15). The stock has a market capitalization of £720.31 million, a price-to-earnings ratio of 10.52, a price-to-earnings-growth ratio of 6.40 and a beta of 0.11. The business's 50-day moving average price is GBX 58.18 and its 200-day moving average price is GBX 63.54. The company has a quick ratio of 1.13, a current ratio of 2.85 and a debt-to-equity ratio of 127.27.
Dr. Martens (LON:DOCS - Get Free Report) last released its quarterly earnings results on Thursday, June 5th. The company reported GBX 2.40 ($0.03) earnings per share for the quarter. Dr. Martens had a net margin of 7.89% and a return on equity of 18.91%. On average, research analysts expect that Dr. Martens plc will post 2.5809394 EPS for the current fiscal year.
Dr. Martens Cuts Dividend
The business also recently disclosed a dividend, which was paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th were given a GBX 0.85 ($0.01) dividend. This represents a yield of 1.47%. The ex-dividend date was Thursday, March 6th. Dr. Martens's dividend payout ratio is 42.53%.
Wall Street Analysts Forecast Growth
Separately, Royal Bank of Canada reduced their price objective on shares of Dr. Martens from GBX 7,000 ($94.84) to GBX 6,000 ($81.29) and set a "sector perform" rating for the company in a report on Monday, May 19th.
Get Our Latest Research Report on Dr. Martens
About Dr. Martens
(
Get Free Report)
Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.
The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.
Recommended Stories
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
